Stonepine Capital Management as of Sept. 30, 2018
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 31 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apollo Endosurgery | 11.6 | $19M | 2.6M | 7.17 | |
| Amarin Corporation | 11.6 | $18M | 1.1M | 16.27 | |
| BioSpecifics Technologies | 10.5 | $17M | 285k | 58.49 | |
| BioDelivery Sciences International | 7.6 | $12M | 4.3M | 2.80 | |
| Cti Biopharma | 5.6 | $9.0M | 4.1M | 2.16 | |
| Melinta Therapeutics | 4.9 | $7.7M | 2.0M | 3.95 | |
| Vanda Pharmaceuticals (VNDA) | 4.7 | $7.4M | 325k | 22.95 | |
| Viveve Med | 4.4 | $7.0M | 2.6M | 2.68 | |
| Cumberland Pharmaceuticals (CPIX) | 4.4 | $7.0M | 1.2M | 5.71 | |
| Alimera Sciences | 4.3 | $6.8M | 7.0M | 0.98 | |
| Ophthotech | 3.5 | $5.5M | 2.3M | 2.36 | |
| Noveliontherapeuti.. | 3.2 | $5.1M | 1.7M | 2.96 | |
| Oxford Immunotec Global | 2.3 | $3.7M | 226k | 16.23 | |
| Correvio Pharma Corp | 2.3 | $3.6M | 898k | 4.02 | |
| Opiant Pharmaceuticals | 2.1 | $3.3M | 186k | 17.86 | |
| Foamix Pharmaceuticals | 2.0 | $3.2M | 551k | 5.73 | |
| Kalvista Pharmaceuticals (KALV) | 1.9 | $3.1M | 138k | 22.11 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.8 | $2.9M | 656k | 4.40 | |
| Htg Molecular Diagnostics | 1.7 | $2.7M | 536k | 5.05 | |
| Alphatec Holdings (ATEC) | 1.6 | $2.5M | 752k | 3.37 | |
| Spero Therapeutics (SPRO) | 1.5 | $2.4M | 226k | 10.51 | |
| Molecular Templates | 1.3 | $2.0M | 378k | 5.39 | |
| Aldeyra Therapeutics (ALDX) | 1.3 | $2.0M | 145k | 13.80 | |
| Catabasis Pharmaceuticals | 1.1 | $1.7M | 2.2M | 0.80 | |
| Xenon Pharmaceuticals (XENE) | 0.8 | $1.3M | 100k | 13.20 | |
| Neos Therapeutics | 0.7 | $1.1M | 228k | 4.85 | |
| Spring Bk Pharmaceuticals In | 0.5 | $856k | 71k | 12.05 | |
| Cancer Genetics | 0.4 | $639k | 614k | 1.04 | |
| Scynexis | 0.3 | $539k | 449k | 1.20 | |
| Sensus Healthcare (SRTS) | 0.2 | $317k | 38k | 8.37 | |
| Dova Pharmaceuticals | 0.1 | $145k | 6.9k | 21.01 |
